Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells

Blood

Volumn 112, Issue 10, 2008, Pages 4039-4047

  Simon, Clotilde ^a,b   Dondi, Elisabetta ^a,b   Chaix, Amandine ^b   De Sepulveda, Paulo ^b   Kubiseski, Terrance J ^c   Varin Blank, Nadine ^a,b   Velazquez, Laura ^a,b,d  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c YORK UNIVERSITY   (Canada)

^d York University ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; LINK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN SH2; RAC PROTEIN; STEM CELL FACTOR; STRESS ACTIVATED PROTEIN KINASE; TYROSINE; LNK PROTEIN, MOUSE; PROTEIN; PROTEIN KINASE B; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WILD TYPE; ANIMAL; BONE MARROW CELL; CELL CULTURE; CELL MOTION; CELL SURVIVAL; CYTOLOGY; ENZYME ACTIVATION; GENETIC TRANSDUCTION; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN;

ANIMALS; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOWN-REGULATION; ENZYME ACTIVATION; HEMATOPOIETIC STEM CELLS; MAP KINASE SIGNALING SYSTEM; MAST CELLS; MICE; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-KIT; SRC HOMOLOGY DOMAINS; STEM CELL FACTOR; TRANSDUCTION, GENETIC;

EID: 58149147644     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-154849     Document Type: Article

References (51)

1. Dawicki W, Marshall SJ. New and emerging roles for mast cells in host defence. Curr Opin Immunol. 2007;19:31-38.
2. Gurish FM, Boyce AJ. Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell. J Allergy Clin Immunol. 2006;117:1285-1291.
3. Ashman KL. The biology of stem cell factor and its receptor c-kit. Int J Biochem Cell Biol. 1999;31: 1037-1051.
4. Okayama Y, Kawakami T. Development, migration, and survival of mast cells. Immunol Res. 2006;34:97-115.
5. Roskoski Jr. R. Signaling by Kit protein-tyrosine kinase: the stem cell factor receptor. Biochem Biophys Res Commun. 2005;337:1-13.
6. Hong L, Munugalavadla V, Kapur R. c-Kitmediated overlapping and unique functional and biochemical outcomes via diverse signaling pathways. Mol Cell Biol. 2004;24:1401-1410.
7. Bayle J, Letard S, Frank R, Dubreuil P, De Sepulveda P. Suppressor of cytokine signaling 6 associates with Kit and regulates Kit receptor signaling. J Biol Chem. 2004;279:12249-12259.
8. De Sepulveda P, Okkenhaug K, La Rose J, Hawley GR, Dubreuil P, Rottapel R. Socs1 binds to multiple signalling proteins and suppresses Steel factor-dependent proliferation. EMBO J. 1999;18:904-915.
9. Kimura Y, Jones N, Klüppel M, et al. Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineages. Proc Natl Acad Sci U S A. 2004; 101:6015-6020.
10. Ueda S, Mizuki M, Ikeda H, et al. Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration. Blood. 2002;99:3342- 3349.
11. Agosti V, Corbacioglu S, Ehlers I, et al. Critical role for Kit-mediated Src kinase but not PI 3- kinase signaling in proT and proB cell development. J Exp Med. 2004;199:867-878.
12. Rudd EC. Lnk adaptor: novel negative regulator of B cell lymphopoiesis. Science STKE. 2001; PE1.
13. Duan C, Yang H, White FM, Rui L. Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance. Mol Cell Biol. 2004;24:7435-7443.
14. Ohtsika S, Takaki S, Iseki M, et al. SH2-B is required for both male and female reproduction. Mol Cell Biol. 2002;22:3066-3077.
15. Iseki M, Kubo C, Kwon S-M, et al. Increased numbers of B-1 cells and enhanced responses against TI-2 antigen in mice lacking APS, an adaptor molecule containing PH and SH2 domains. Mol Cell Biol. 2004;24:2243-2250.
16. Minami A, Iseki M, Kishi K, et al. Increased insulin sensitivity and hypoinsulinemia in APS knockout mice. Diabetes. 2003;52:2657-2665.
17. Takaki S, Sauer K, Iritani MB, et al. Control of B cell production by the adaptor protein Lnk: definition of a conserved family of signal-modulating proteins. Immunity. 2000;13:599-609.
18. Velazquez L, Cheng MA, Fleming EH, et al. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med. 2002;195:1599-1611.
19. Takaki S, Morita H, Tezuka Y, Takatsu K. Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk. J Exp Med. 2002;195:151-160.
20. Buza-Vidas N, Antonchuk J, Qian H, et al. Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK. Genes Dev. 2006;20:2018-2023.
21. Seita J, Ema H, Ooehara J, et al. Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Proc Natl Acad Sci U S A. 2007; 104:2349-2354.
22. Tong W, Lodish FH. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med. 2004;200:569-580.
23. Tong W, Lodish FH. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood. 2005;105: 4604-4612.
24. Nobuhisa I, Takizawa M, Takaki S, et al. Regulation of hematopoietic development in the Aorta- Gonad-Mesonephros region mediated by Lnk adaptor protein. Mol Cell Biol. 2003;23:8486- 8494.
25. Takizawa H, Kubo-Akashi C, Nobuhisa I, et al. Enhanced engraftment of hematopoietic stem/ progenitor cells by the transient inhibition of an adaptor protein, Lnk. Blood. 2006;107:2968- 2975.
26. Rottapel R, Reedijk M, Williams ED, et al. The Steel/W transduction pathway: Kit autophosphorylation amd its association with a unique subset of cytoplasmic signalling proteins induced by Steel factor. Mol Cell Biol. 1991;11:3043-3051.
27. Frank R. Spot-synthesis: an easy technique for positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron. 1992;48:9217-9232.
28. Millot AG, Vainchenker W, Dume' nil D, Svinarchuk F. Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells. J Cell Sci. 2002;115:2329-2337.
29. Bernstein ID, Andrews GR, Zsebo MK. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells cultured with interleukin-3, granulocyte colonystimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood. 1991;77:2316- 2321.
30. Ghia P, ten Boekel E, Rolink AG, Melchers F. B-cell development: a comparison between mouse and man. Immunol Today. 1998;19:480- 485.
31. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood. 1992;79:958-963.
32. Samayawardhena AL, Hu J, Stein LP, Craig WBA. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor. Cell Signal. 2006;18:1447-1454.
33. Tan LB, Yazicioglu NM, Ingram D, et al. Genetic evidence for convergence of c-Kit and α4 integrin-mediated signals on class IA PI-3-kinase and the Rac pathway in regulating integrin-directed migration in mast cells. Blood. 2003;101: 4725-4732.
34. Sundström M, Alfredsson J, Olsson N, Nilsson G. Stem cell factor-induced migration of mast cells requires p38 mitogen-activated protein kinase activity. Exp Cell Res. 2001;267:144-151.
35. Wollberg P, Lennartsson J, Gottridsson E, Yoshimura A, Rönnstrand L. The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit. Biochem J. 2003;370:1033-1038.
36. Chan MP, Ilangumaran S, La Rose J, Chakrabartty A, Rottapel R. Autoinhibition of the Kit receptor tyrosine kinase by the cytosolic juxtamembrane region. Mol Cell Biol. 2003;23:3067- 3078.
37. Li Y, He X, Schembri-King J, Jakes S, Hayashi J. Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation. J Immunol. 2000;164:5199-5206.
38. Takaki S, Tezuka Y, Sauer K, et al. Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein. J Immunol. 2003;170:703-710.
39. Timokhina I, Kissel H, Stella G, Besmer P. Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation. EMBO J. 1998;17: 6250-6262.
40. Cancelas AJ, Jansen M, Williams AD. The role of chemokine activation of Rac GTPases in hematopoietic stem cell marrow homing, retention, and peripheral mobilization. Exp Hematol. 2006;34: 976-985.
41. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420:629-635.
42. Barrés R, Gonzalez T, Le Marchand-Brustel Y, Tanti JF. The interaction between the adaptor protein APS and Enigma is involved in actin organisation. Exp Cell Res. 2005;308:334-344.
43. Diakonova M, Gunter RD, Herrington J, Carter-Su C. SH2-Bβ is a Rac1-binding protein that regulates cell motility. J Biol Chem. 2002; 277:10669-10677.
44. Yabana N, Shibuya M. Adaptor protein APS binds the NH2-terminal autoinhibitory domain of guanine nucleotide exchange factor Vav3 and augments its activity. Oncogene. 2002;21:7720-7729.
45. He X, Li Y, Schembri-King J, Jakes S, Hayashi J. Identification of actin binding protein ABP-280, as a binding partner of human Lnk adaptor protein. Mol Immunol. 2000;37:603-612.
46. Yu M, Luo J, Yang W, et al. The scaffolding adapter Gab2, via Shp-2, regulates Kit-evoked mast cell proliferation by activating the Rac/JNK pathway. J Biol Chem. 2006;281:28615-28626.
47. O'Laughlin-Bunner B, Radosevic N, Taylor LM, et al. Lyn is required for normal stem cell factorinduced proliferation and chemotaxis of primary hematopoietic cells. Blood. 2001;98:343-350.
48. Shivakrupa R, Linnekin D. Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells. Cell Signal. 2005;17:103-109.
49. Hernandez-Hansen V, Mackay GA, Lowell CA, Wilson BS, Oliver JM. The Src kinase Lyn is a negative regulator of mast cell proliferation. J Leukoc Biol. 2004;75:143-151.
50. Kitamura Y, Hirota S. Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci. 2004;61:2924- 2931.
51. Paulson FR, Vesely S, Siminovitch AK, Bernstein A. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nat Genet. 1996;13: 309-315.